GENELUX CORPORATION
GNLX·36870H103·US·Common Stock·Healthcare - Biotechnology-13D/G
GNLX (GENELUX CORPORATION) is held by 36 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($4.1M), GEODE CAPITAL MANAGEMENT, LLC ($1.1M), BlackRock, Inc. ($982,210). Net institutional sentiment: Mixed.
36
Holders
(1 Elite)
$10.6M
Total Value
41% (41)
Consensus
17 buying - 24 selling
13F: Insider & Congress:
Who's Trading
InsiderZTZindrick ThomasSell $8KMay 11, 2026
InsiderCJCappello JosephSell $2KMay 11, 2026
InsiderYYYu YongSell $2KMay 11, 2026
InsiderSRSmalling RalphSell $804.49May 11, 2026
InsiderSRSmalling RalphSell $602.4Mar 25, 2026
InsiderZTZindrick ThomasSell $9KMar 24, 2026
InsiderCJCappello JosephSell $2KMar 24, 2026
InsiderYYYu YongSell $2KMar 24, 2026
ActivistASAladar Szalay8.2%Feb 17, 2026
ActivistARArmistice Capital, LLC10.0%Nov 14, 2025
Top Holders
Showing 1-20 of 49
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
413 holders · $666.6B
413 holders · $186.3B
394 holders · $391.3B
392 holders · $97B
391 holders · $123.5B
391 holders · $147B
389 holders · $76.8B
385 holders · $208.9B
381 holders · $254.9B
380 holders · $129.1B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer